Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...

Going forward, we may see more instances in which insurers deny or (temporarily) severely restrict coverage of accelerated ...

The FDA approved a pain drug designed to eliminate the risks associated with opioids -- the first new pharmaceutical approach ...

The approval Journey Medical received from FDA for Emrosi makes DERM an exciting stock. Click here to read more.

Amid the uproar over the firing of 18 inspectors general, a report offering a coda to the aducanumab approval episode has ...

Understanding the reasoning and process of Medicare Advantage prior authorization can help you gain faster approval for a required prior authorization.

The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...

The STAY study aims to change this reality. Researchers hope that the new drug will slow down the ageing process, improve ...

RenovoRx's innovative RenovoCath and TAMP platform show promising clinical data. Click here to read why RNXT stock presents ...

At the end of 2024, more than 50 authorized treatment centers in the U.S. had initiated the treatment process with over 50 patients. In December, the FDA approved Alyftrek, a new once-daily pill ...

APAC offers stability in an increasing challenging global geopolitical environment for clinical stage drug development.